LSM14B: A Potential Drug Target and Biomarker (G149986)

Target Name: LSM14B

NCBI ID: G149986

LSM14B

LSM14B: A Potential Drug Target and Biomarker

LSM14B (LSM14B gene, also known as SCD6 homolog B) is a gene that encodes a protein involved in the process of intracellular signaling. The protein produced by LSM14B has been shown to play a role in a variety of cellular processes, including cell adhesion, migration, and invasion. LSM14B has also been implicated in the development and progression of several diseases, including cancer. As a result, LSM14B has emerged as a promising drug target and biomarker for a variety of therapeutic applications.

Diseases associated with LSM14B

LSM14B has been implicated in the development and progression of several diseases, including cancer. For example, studies have shown that LSM14B is overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. Overexpression of LSM14B has been shown to promote the growth and survival of cancer cells, as well as the development of invasive and metastatic phenotypes.

In addition to its role in cancer, LSM14B has also been implicated in the development of other diseases. For example, LSM14B has been shown to be overexpressed in individuals with Down syndrome, a genetic disorder that is characterized by a range of developmental and cognitive impairments. Overexpression of LSM14B in individuals with Down syndrome has been shown to contribute to the severity of their symptoms and the development of certain health problems, including cardiovascular disease and neurodegeneration.

Potential therapeutic applications

The potential therapeutic applications for LSM14B are vast and varied. As a drug target, LSM14B could be target

Protein Name: LSM Family Member 14B

Functions: Required for oocyte meiotic maturation. May be involved in the storage of translationally inactive mRNAs and protect them from degradation (By similarity). Plays a role in control of mRNA translation (By similarity)

The "LSM14B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LSM14B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets